Loading
The US defense department's ovarian cancer research fund, started in 1997. It funds work from basic biology to clinical trials, including early detection and survivorship, and has received about 557 million dollars.
The Ovarian Cancer Research Program was initiated in FY97 to support high-impact research that fills unmet needs, setting priorities along the pipeline from basic to translational to clinical research, including clinical trials. Its stated vision is "to eliminate ovarian cancer". Its current areas of emphasis are the basic biology and causes of initiation, progression, metastasis and recurrence; new strategies for treatment and prevention; screening, early detection, accurate diagnosis and prognosis; survivorship and quality of life; and precision medicine.
The page lists congressional appropriations of $556.5 million for FY97 to FY25 and $50 million for FY26, and 729 awards in FY97 to FY24.
Shares Congressionally Directed Medical Research Programs (CDMRP), The hardest cancers are found late and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP), The hardest cancers are found late and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/